# Phase I Study MR-guided SBRT to PCa

> **NCT03935308** · NA · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Low or Intermediate Risk Prostate Cancer

## Interventions

- **RADIATION:** MR guided Linear Accelerator

## Key facts

- **NCT ID:** NCT03935308
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-04-23
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The principal investigator left the institution.
- **Last updated:** 2022-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03935308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03935308, "Phase I Study MR-guided SBRT to PCa". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03935308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*